Search
Navigation
Join our mailing list!
(Your shopping cart is empty)
Home
>
Diane Publishing Books
>
Impact of Gene Expression Profiling Tests on Breast Cancer Outcomes
Our Price:
$
45.00
By
Luigi Marchionni (au)
Year:
2008
Pages:
221
Binding
Paperback
Product Code:
1437911048
Description
Assesses the evidence that three marketed gene expression-based assays improve prognostic accuracy, treatment choice, and health outcomes in women diagnosed with early stage breast cancer. Three gene expression assays were evaluated; Oncotype DX™, MammaPrint® and the Breast Cancer Profiling (BCP or H/I ratio) test, and for gene expression signatures underlying the assays. They sought evidence on: analytic performance of tests; clinical validity; clinical utility; harms; and impact on clinical decision making and health care costs. Conclusions: Oncotype DX is furthest along the validation pathway, with retrospective evidence that it predicts distant spread and chemotherapy benefit to a clinically relevant extent over standard predictors. Illus.
Related Products...
Competing for Employees: Proven Marketing Strategies for Hiring & Keeping Exceptional People
Our Price:
$25.00
Add
Customer Service Operations: The Complete Guide
Our Price:
$40.00
Add
Sagas of Icelanders: A Selection
Our Price:
$40.00
Add
Comes the Millennium
Our Price:
$22.00
Add
Woman’s Guide to Making Therapy Work
Our Price:
$20.00
Add
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
1-800-782-3833
About Us
Become an Affiliate
Privacy Policy
Send Us Feedback
Company Info
|
Advertising
|
Product Index
|
Category Index
|
Help
|
Terms of Use
Copyright � 2004 Diane Publishing Company. All Rights Reserved.
Built with
Volusion